NutriRoot Touts Scalp Care Amid New GLP-1 Hair Thinning Research

NutriRoot is promoting new scalp care resources as fresh research from Penn Medicine links GLP-1 medications with a higher risk of hair loss diagnoses in adults with type 2 diabetes. The company says its routine is aimed at people noticing shedding during periods of major physical change, when nutrition and stress can affect hair health.

Why it matters: - Hair thinning can become an unwanted side effect for some people taking GLP-1 medications, adding another concern for adults managing weight or diabetes treatment. - The new research adds to growing attention on how rapid body changes, diet shifts and nutrient deficiencies can affect hair shedding. - NutriRoot is using that backdrop to position scalp care as a simple routine for people looking for topical support.

What happened: - A new Penn Medicine study published in The BMJ found adults with type 2 diabetes who started GLP-1 medications had a 37% higher risk of a hair loss diagnosis than those who started SGLT-2 inhibitors. - The same group had a 68% higher risk than patients who started DPP-4 inhibitors. - The analysis covered patients who began treatment between 2019 and 2024. - NutriRoot announced new educational resources and a dedicated scalp care routine for adults who notice changes in their hair during periods of significant physical change. - The company also highlighted a daily Strengthening Serum and treatment wash as part of its topical system.

The details: - The study found the increase was concentrated in non-scarring hair loss, where follicles remain intact. - The researchers said the absolute risk remained low. - The authors pointed to rapid body changes and related nutritional deficiencies, including low iron or zinc, as known triggers for shedding. - NutriRoot said its system uses the brand’s patented Brassinosteroid complex, derived from botanicals and minerals of the Dead Sea region. - The formula was developed by Dr. Amir Kitron. - In a separate 12-week consumer use study by Zurko Research in Spain, women ages 30 to 50 reported results after using NutriRoot. - In that study, 92% reported overall satisfaction, 84% reported visibly increased hair density, 77% reported noticeably reduced shedding, and 69% reported thicker, stronger-looking hair. - The company said the study was not conducted specifically among GLP-1 users. - NutriRoot products are available at nutriroot.co and come in formulas for original and blonde hair.

Between the lines: - The study does not prove GLP-1 drugs directly cause hair loss, but it strengthens the case that some users experience shedding during major metabolic change. - NutriRoot is framing scalp care as a practical response to a side effect that may be temporary and linked to stress on the body. - The company’s messaging also leans on the idea that consistency matters more than a complex regimen.

What's next: - More patients and clinicians may watch for hair changes when starting GLP-1 treatment, especially if rapid weight loss or nutritional gaps are also present. - NutriRoot is likely to keep marketing its scalp-focused routine to people seeking a low-effort hair care option during periods of change.

The bottom line: - The new research adds another reason for GLP-1 users to monitor hair shedding, while NutriRoot is pitching a simple topical routine as part of the response.